• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

碘海醇与乳果糖-甘露醇试验作为炎症性肠病患者疾病活动标志物的比较。

Comparison of iohexol and lactulose-mannitol tests as markers of disease activity in patients with inflammatory bowel disease.

作者信息

Halme L, Turunen U, Tuominen J, Forsström T, Turpeinen U

机构信息

Fourth Department of Surgery, Helsinki University Hospital, Finland.

出版信息

Scand J Clin Lab Invest. 2000 Dec;60(8):695-701. doi: 10.1080/00365510050216420.

DOI:10.1080/00365510050216420
PMID:11218152
Abstract

Increased intestinal permeability has been proposed as one aetiological factor for inflammatory bowel diseases (IBD). We have previously found that intestinal permeability of a water-soluble contrast medium, iohexol, correlates with disease activity. The objective was to compare the iohexol test with the lactulose-mannitol ratio, which is a more extensively studied permeability marker, in patients with active IBD. Urinary excretion of iohexol was compared to the lactulose-mannitol ratio in 22 patients with an exacerbation of IBD and in 10 healthy controls. Median intestinal absorption of iohexol was 0.64% (range 0.13-3.8%) in the 22 patients and 0.3% (range 0.15-0.54%) in the controls (p = 0.016), whereas the median lactulose-mannitol ratio was 0.037 (range 0.01-0.260) in patients and 0.03 (range 0.004-0.063) in controls (N.S.). Correlation between urinary excretion of iohexol and lactulose-mannitol ratio was positive (R = +0.41, p = 0.018). The urinary excretion of iohexol correlated positively with endoscopic disease activity (R = +0.74, p < 0.001) and the modified Harvey-Bradshaw index (R = +0.44, p = 0.04). The lactulose-mannitol ratio correlated positively with endoscopic disease activity (R = +0.44, p = 0.05), but correlations with clinical index or c-reactive protein were poor. In conclusion, the iohexol test is a superior activity marker compared to the lactulose-mannitol ratio which probably reflects, instead, some pathogenic property of IBD.

摘要

肠道通透性增加已被认为是炎症性肠病(IBD)的一个病因。我们之前发现,水溶性造影剂碘海醇的肠道通透性与疾病活动度相关。目的是在活动性IBD患者中比较碘海醇试验与乳果糖-甘露醇比值,后者是一种研究更为广泛的通透性标志物。比较了22例IBD病情加重患者和10名健康对照者碘海醇的尿排泄量与乳果糖-甘露醇比值。22例患者碘海醇的肠道吸收中位数为0.64%(范围0.13 - 3.8%),对照组为0.3%(范围0.15 - 0.54%)(p = 0.016),而患者乳果糖-甘露醇比值中位数为0.037(范围0.01 - 0.260),对照组为0.03(范围0.004 - 0.063)(无统计学意义)。碘海醇尿排泄量与乳果糖-甘露醇比值呈正相关(R = +0.41,p = 0.018)。碘海醇尿排泄量与内镜下疾病活动度呈正相关(R = +0.74,p < 0.001)以及与改良的Harvey - Bradshaw指数呈正相关(R = +0.44,p = 0.04)。乳果糖-甘露醇比值与内镜下疾病活动度呈正相关(R = +0.44,p = 0.05),但与临床指标或C反应蛋白的相关性较差。总之,与乳果糖-甘露醇比值相比,碘海醇试验是一种更优的活动度标志物,而乳果糖-甘露醇比值可能反映的是IBD的一些致病特性。

相似文献

1
Comparison of iohexol and lactulose-mannitol tests as markers of disease activity in patients with inflammatory bowel disease.碘海醇与乳果糖-甘露醇试验作为炎症性肠病患者疾病活动标志物的比较。
Scand J Clin Lab Invest. 2000 Dec;60(8):695-701. doi: 10.1080/00365510050216420.
2
Gut permeability to lactulose and mannitol differs in treated Crohn's disease and celiac disease patients and healthy subjects.在接受治疗的克罗恩病患者、乳糜泻患者和健康受试者中,肠道对乳果糖和甘露醇的通透性存在差异。
Braz J Med Biol Res. 2008 Dec;41(12):1105-9. doi: 10.1590/s0100-879x2008001200010.
3
Is moderate red wine consumption safe in inactive inflammatory bowel disease?在非活动性炎症性肠病中,适量饮用红酒是否安全?
Digestion. 2011;84(3):238-44. doi: 10.1159/000329403. Epub 2011 Aug 26.
4
Evaluation of the lactulose/mannitol and 51Cr-ethylenediaminetetraacetic acid/14C-mannitol methods for intestinal permeability.乳果糖/甘露醇法和51铬-乙二胺四乙酸/14碳-甘露醇法评估肠道通透性
Scand J Gastroenterol. 1997 Aug;32(8):805-12. doi: 10.3109/00365529708996538.
5
Comparison between lactulose-mannitol test and 51Cr-labelled ethylene diamine tetra-acetate test in inflammatory bowel diseases.乳果糖-甘露醇试验与51Cr标记乙二胺四乙酸试验在炎症性肠病中的比较
Hepatogastroenterology. 1990 Dec;37 Suppl 2:113-7.
6
Comparison between the lactulose/mannitol and 51Cr-ethylenediaminetetraacetic acid/14C-mannitol methods for intestinal permeability. Frequency distribution pattern and variability of markers and marker ratios in healthy subjects.乳果糖/甘露醇法与51铬-乙二胺四乙酸/14C-甘露醇法检测肠道通透性的比较。健康受试者中标志物及其比值的频率分布模式和变异性。
Scand J Gastroenterol. 1993 Mar;28(3):274-80. doi: 10.3109/00365529309096085.
7
Urinary excretion of iohexol as a marker of disease activity in patients with inflammatory bowel disease.以碘海醇尿排泄量作为炎症性肠病患者疾病活动度的标志物
Scand J Gastroenterol. 1997 Feb;32(2):148-52. doi: 10.3109/00365529709000185.
8
Patients with ankylosing spondylitis and healthy relatives do not show increased small intestinal permeability with the lactulose-mannitol test.强直性脊柱炎患者及其健康亲属在进行乳果糖-甘露醇试验时,并未表现出小肠通透性增加。
Clin Exp Rheumatol. 1993 Jul-Aug;11(4):413-6.
9
Assessment of intestinal permeability with a two-hour urine collection.通过收集两小时尿液评估肠道通透性。
Dig Dis Sci. 1998 Sep;43(9):1946-50. doi: 10.1023/a:1018826307489.
10
Increased intestinal permeability in patients with inflammatory bowel disease.炎症性肠病患者肠道通透性增加。
Eur J Med Res. 2004 Oct 29;9(10):456-60.

引用本文的文献

1
Integrating the lactulose-mannitol test for intestinal permeability with untargeted metabolomics for drug monitoring through dual liquid chromatography-mass spectrometry.将用于肠道通透性检测的乳果糖-甘露醇试验与通过二维液相色谱-质谱联用进行药物监测的非靶向代谢组学相结合。
Anal Bioanal Chem. 2025 May;417(13):2767-2781. doi: 10.1007/s00216-025-05790-7. Epub 2025 Feb 27.
2
Ketogenic Diet High in Saturated Fat Promotes Colonic Claudin Expression without Changes in Intestinal Permeability to Iohexol in Healthy Mice.高脂肪生酮饮食促进健康小鼠结肠紧密连接蛋白表达而不改变肠道对碘海醇的通透性。
Nutrients. 2023 Dec 20;16(1):18. doi: 10.3390/nu16010018.
3
IL-1β and the Intestinal Epithelial Tight Junction Barrier.
白细胞介素-1β与肠道上皮紧密连接屏障。
Front Immunol. 2021 Oct 25;12:767456. doi: 10.3389/fimmu.2021.767456. eCollection 2021.
4
Urinary Excretion of Iohexol as a Permeability Marker in a Mouse Model of Intestinal Inflammation: Time Course, Performance and Welfare Considerations.碘海醇的尿排泄作为肠道炎症小鼠模型中的通透性标志物:时间进程、性能及福利考量
Animals (Basel). 2021 Jan 4;11(1):79. doi: 10.3390/ani11010079.
5
The Effects of Exercise on Indirect Markers of Gut Damage and Permeability: A Systematic Review and Meta-analysis.运动对肠道损伤和通透性间接标志物的影响:系统评价与荟萃分析
Sports Med. 2021 Jan;51(1):113-124. doi: 10.1007/s40279-020-01348-y.
6
Exercise and gastrointestinal symptoms: running-induced changes in intestinal permeability and markers of gastrointestinal function in asymptomatic and symptomatic runners.运动与胃肠道症状:无症状和有症状跑者中,跑步引起的肠道通透性改变和胃肠道功能标志物变化。
Eur J Appl Physiol. 2017 Dec;117(12):2519-2526. doi: 10.1007/s00421-017-3739-1. Epub 2017 Oct 14.
7
Intestinal permeability to iohexol as an in vivo marker of chemotherapy-induced gastrointestinal toxicity in Sprague-Dawley rats.肠道对碘海醇的通透性作为Sprague-Dawley大鼠化疗诱导的胃肠道毒性的体内标志物。
Cancer Chemother Pharmacol. 2016 Oct;78(4):863-74. doi: 10.1007/s00280-016-3150-3. Epub 2016 Sep 2.
8
Methods to determine intestinal permeability and bacterial translocation during liver disease.测定肝病期间肠道通透性和细菌移位的方法。
J Immunol Methods. 2015 Jun;421:44-53. doi: 10.1016/j.jim.2014.12.015. Epub 2015 Jan 13.
9
Standardising the lactulose mannitol test of gut permeability to minimise error and promote comparability.规范乳果糖-甘露醇肠道通透性试验,以尽量减少误差并提高可比性。
PLoS One. 2014 Jun 5;9(6):e99256. doi: 10.1371/journal.pone.0099256. eCollection 2014.
10
Increased intestinal permeability in inflammatory bowel diseases assessed by iohexol test.应用碘海醇试验评估炎症性肠病的肠道通透性增加。
World J Gastroenterol. 2011 May 7;17(17):2211-5. doi: 10.3748/wjg.v17.i17..